Comparing standard and low-dose continuous renal replacement therapy for acute kidney injury
Official title: A Randomized Controlled Study Investigating Standard Dose Continuous Renal Replacement Therapy (CRRT) Versus Low-Dose CRRT - The "Ketzerei" Trial
Run by Universität Münster · NCT06021288 · Data updated 2026-11-12
This study tests whether using a standard dose or a lower dose of a kidney treatment can help critically ill patients with acute kidney injury recover better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 165 (estimated) |
| Sponsor | Universität Münster Academic / other |
| Locations | 2 sites (Münster and 1 other locations) |
| Status | Recruiting |
| Started | October 2, 2023 |
| Main results expected | April 30, 2025 |
| Study ends | June 30, 2025 |
| Registry record updated | November 27, 2024 |
| Trial ID | NCT06021288 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are critically ill adults aged 18 and older who are experiencing acute kidney injury and require continuous renal replacement therapy.
✕Probably not a fit
Patients who are chronically dependent on dialysis or have severe comorbid conditions such as chronic kidney disease or severe liver cirrhosis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients suffering from acute kidney injury (AKI). The research aims to determine if a controlled level of azotaemia can lead to improved renal recovery in these patients. By enrolling adult patients who require CRRT, the study will assess the outcomes associated with different dosing strategies of CRRT. The findings could provide insights into optimizing treatment protocols for AKI in critical care settings.
Why it matters
Potential benefit: If successful, this study could lead to improved renal recovery rates in critically ill patients with acute kidney injury.
How similar studies have gone: While there is ongoing research in the area of CRRT, this specific comparison of standard versus low-dose CRRT is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (age ≥18 years) * Critically ill patients with AKI + in need of CRRT * Written informed consent Exclusion Criteria: * Chronic dialysis dependency * Chronic kidney disease with estimated glomerular filtration rate (eGFR) \<30 ml/min/1.73m² * severe liver cirrhosis (Child-pugh C) * severe acidosis (pH \< 7,20 at study enrolment) * severe hyperkalaemia (\> 6mmol/l) * Pregnancy or breastfeeding * persons held in an institution by legal or official order * Dependency on the investigator or center
Where it's running
-
University Hospital Münster
Münster, Germany Recruiting -
Universitätsklinikum Tübingen; Universitätsklinik für Anästhesiologie und Intensivmedizin
Tübingen, Germany Recruiting
Study contacts
- Study coordinator: Alexander Zarbock, MD
- Email: aki@anit.uni-muenster.de
- Phone: +492518347255
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how patients tolerate fluid removal during kidney support in the ICU
This observational study tests how well critically ill adults with acute kidney injury tolerate net fluid removal during continuous renal replacement therapy.
-
Sodium bicarbonate for critically ill patients with metabolic acidosis and AKI
This trial tests whether giving sodium bicarbonate helps reduce major kidney problems 90 days later in adults with septic or critical illness and kidney injury.
-
Choosing Wisely recommendations for care in the intensive care unit
This project will try the Choosing Wisely approach in adult ICU patients in Sweden to see if using fewer unnecessary tests and interventions is safe.
-
Using renal resistive index to predict acute kidney injury in high-risk patients
This study is testing if measuring kidney blood flow using ultrasound can help doctors spot acute kidney injury earlier in high-risk patients in the intensive care unit.
-
Understanding brain health in ICU patients with kidney injury
This study looks at how kidney injury affects brain health in critically ill adults in the ICU to see if measuring brain oxygen levels can help predict long-term thinking and memory problems.
-
Using albumin to improve recovery in critically ill patients with acute kidney injury
This study is testing whether giving critically ill patients with acute kidney injury a special type of albumin instead of regular saline can help them recover better and need less kidney treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.